CNMD

SEC source: 0000816956-26-000105 · form4.xml · derivative · entry 2

Kelderman Kim · CIK 0001739054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 500 shares

Expires 2035-09-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000105 · form4.xml · nonDerivative · entry 1

Kelderman Kim · CIK 0001739054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000096 · form4.xml · derivative · entry 3

Gallagher John E · CIK 0001628991 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,536

Underlying: Common Stock · 30,536 shares

Expires 2036-07-15

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000096 · form4.xml · derivative · entry 2

Gallagher John E · CIK 0001628991 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,929

Underlying: Common Stock · 26,875 shares

Expires 2036-07-15

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000096 · form4.xml · derivative · entry 1

Gallagher John E · CIK 0001628991 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,054

Underlying: Common Stock · 35,054 shares

Expires 2036-07-15

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000087 · form4.xml · derivative · entry 1

Martin Celine Christine · CIK 0002092680 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,603

Underlying: Common Stock · 5,603 shares

Expires 2036-07-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000085 · form4.xml · derivative · entry 1

Mirviss Jeffrey B. · CIK 0001566094 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,603

Underlying: Common Stock · 5,603 shares

Expires 2036-07-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000075 · form4.xml · derivative · entry 3

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668 shares

Expires 2035-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000075 · form4.xml · nonDerivative · entry 1

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000073 · form4.xml · derivative · entry 3

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668 shares

Expires 2035-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000073 · form4.xml · nonDerivative · entry 1

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000069 · form4.xml · derivative · entry 3

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668 shares

Expires 2035-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000069 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000067 · form4.xml · derivative · entry 3

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668 shares

Expires 2035-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000067 · form4.xml · nonDerivative · entry 1

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000065 · form4.xml · derivative · entry 4

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668 shares

Expires 2035-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000065 · form4.xml · nonDerivative · entry 1

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000075 · form4.xml · derivative · entry 2

Bronson David M. · CIK 0001183762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000073 · form4.xml · derivative · entry 2

Council LaVerne H · CIK 0001788616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000071 · form4.xml · derivative · entry 1

Kelderman Kim · CIK 0001739054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000069 · form4.xml · derivative · entry 2

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000067 · form4.xml · derivative · entry 2

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000065 · form4.xml · derivative · entry 3

Schwarzentraub Barbara J · CIK 0001788466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,772

Underlying: Common Stock · 5,772 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

SEC source: 0000816956-26-000041 · form4.xml · derivative · entry 1

Beyer Pat · CIK 0001627985 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,145

Underlying: Common Stock · 28,145 shares

Expires 2036-04-01

F1 · derivative.exercise_date: On March 23rd, 2026, the CONMED Board of Directors approved an additional equity award for the CEO of $1M in target value to be granted in the form of RSUs and scheduled to vest starting April 1st, 2026 over 3-years in three equal annual tranches with a 2-year post-vest holding period to be applied to net after tax shares after each vesting event.

SEC source: 0000816956-26-000029 · form4.xml · derivative · entry 3

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75 shares

Expires 2032-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.

SEC source: 0000816956-26-000029 · form4.xml · nonDerivative · entry 2

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 915.057

SEC source: 0000816956-26-000029 · form4.xml · nonDerivative · entry 1

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 941.057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports.

SEC source: 0000816956-26-000027 · form4.xml · derivative · entry 2

Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,646

Underlying: Common Stock · 11,646 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000027 · form4.xml · derivative · entry 1

Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,827

Underlying: Common Stock · 9,827 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000025 · form4.xml · derivative · entry 2

Ferrell John D. · CIK 0001980620 · Executive Vice President - HR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,999

Underlying: Common Stock · 10,999 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000025 · form4.xml · derivative · entry 1

Ferrell John D. · CIK 0001980620 · Executive Vice President - HR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,282

Underlying: Common Stock · 9,282 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000023 · form4.xml · derivative · entry 1

Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,896

Underlying: Common Stock · 5,896 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000021 · form4.xml · derivative · entry 2

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,999

Underlying: Common Stock · 10,999 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000021 · form4.xml · derivative · entry 1

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,282

Underlying: Common Stock · 9,282 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000017 · form4.xml · derivative · entry 2

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,940

Underlying: Common Stock · 12,940 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000017 · form4.xml · derivative · entry 1

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,919

Underlying: Common Stock · 10,919 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000015 · form4.xml · derivative · entry 1

Moller Andrew James · CIK 0002054340 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,896

Underlying: Common Stock · 5,896 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000019 · form4.xml · derivative · entry 2

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,322

Underlying: Common Stock · 11,322 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000019 · form4.xml · derivative · entry 1

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,554

Underlying: Common Stock · 9,554 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000013 · form4.xml · derivative · entry 2

Beyer Pat · CIK 0001627985 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,258

Underlying: Common Stock · 68,258 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

SEC source: 0000816956-26-000013 · form4.xml · derivative · entry 1

Beyer Pat · CIK 0001627985 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,800

Underlying: Common Stock · 28,800 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC source: 0000816956-26-000037 · form4a.xml · derivative · entry 1

Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,471

Underlying: Common Stock · 17,471 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted.

SEC source: 0000816956-26-000039 · form4a.xml · derivative · entry 1

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,198

Underlying: Common Stock · 17,198 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,554 shares for a total of 17,198 RSUs granted.

SEC source: 0000816956-26-000033 · form4a.xml · derivative · entry 1

Ferrell John D. · CIK 0001980620 · Executive Vice President - HR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,926

Underlying: Common Stock · 16,926 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.

SEC source: 0000816956-26-000035 · form4a.xml · derivative · entry 1

Foust Hollie K · CIK 0002043157 · General Counsel & Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,563

Underlying: Common Stock · 18,563 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 10,919 shares for a total of 18,563 RSUs granted.

SEC source: 0000816956-26-000031 · form4a.xml · derivative · entry 1

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,926

Underlying: Common Stock · 16,926 shares

Expires 2036-03-02

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.

SEC source: 0000816956-26-000011 · form4.xml · derivative · entry 2

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 152 shares

Expires 2035-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

SEC source: 0000816956-26-000011 · form4.xml · nonDerivative · entry 1

Kaye Mark · CIK 0001748691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000816956-26-000002 · form5.xml · nonDerivative · entry 1

Lalomia Brent · CIK 0001921560 · Executive VP RA, QA

10b5-1 filing: No plan indicated

Ownership: Indirect · 401 (K) Plan

Disclosed balance after: 125.232

F1 · date: As of December 31, 2025.

F2 · balance_after: Between January 1, 2025 and December 31, 2025, the reporting person acquired 31.626 shares of CNMD common stock under the CNMD 401(k) plan. The information in this report is based on a plan statement dated as of December 31, 2025.

SEC source: 0000816956-25-000063 · form4.xml · nonDerivative · entry 1

Glaze Richard · CIK 0002025615 · Chief Information Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0